Terrence Sullivan

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis

M. Mamdani, C. Bell, S. Peacock, 2014, BMC Cancer.

Great expectations: patients’ preferences for clinically significant results from genomic sequencing

A. Laupacis, C. Earle, Y. Bombard, 2023, Human Genetics.